The Europe Protein A Resins Market was worth $105.2 million in 2016 and estimated to be growing at a CAGR of 9.11%, to reach $162.7 million by 2021. The market is showing evident potential in the mentioned forecast period. Increasing research and development activities on monoclonal antibodies is expected to drive sales of Protein A resins in the future.

European market for Protein A Resins is driven by factors such as growing demand for biosimilars and increasing investments into the research and development of biosimilar products while factors such as increasing awareness about alternate methods to purify monoclonal antibodies and high cost of these products are anticipated to hamper the growth of Protein A Resins market.

European market for Protein A resin is segmented by product type, application, matrix type and end user. Based on product the market is further segmented into Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing product segment. By application protein A Resin market is analysed as Immuno precipitation and Antibody Purification. Immuno precipitation segment is estimated to be the fastest growing. Based on Matrix type Europe Protein A Resin market is segmented into Glass or Silica, Agarose and Organic Polymer. Among the matrix type agarose accounts for the largest share and is estimated to continue its strong share during the forecast period. By end user the market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions.

Geographically Europe Protein A resin market is analysed under various regions namely United Kingdom, Germany, Italy, Spain, France, Russia and Poland. Within Europe, United Kingdom is largest market for Protein A resins whereas Spain is estimated to be the fastest growing region.

Some of the major companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.